Ze-Min Lin (Zemin Lin)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Rheumatoid Arthritis

Ankylosing Spondylitis

Disease Activity

Top Venues

Signal transduction and targeted therapy

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Shi-Jun He, Jian-Ping Zuo, Ze-Min Lin
Androgen-type 2 innate lymphoid cells-dendritic cell axis modulates sex-associated differences in skin immune responses. MedComm 5 (10) (2024)
Mei-Lin Tang, Xiao-Yu Xiong, Heyanhao Zhang, Yun-Zhi Wang, Rong-Qian Cheng, Jianping Zuo, Lin Jin, Ze-Min Lin, Jun Chang
From Hit to Lead: Discovery of First-In-Class Furanone Glycoside D228 Derived from Chimonanthus salicifolius for the Treatment of Inflammatory Bowel Disease. Journal of medicinal chemistry (2024)
Shi-Jun He, Jian-Ping Zuo, Ze-Min Lin
Interplay of IL-17A/IL-17RA signaling with microbial homeostasis in systemic anti-tumoral responses. MedComm 5 (4) (2024)
Shi-Jun He, Jian-Ping Zuo, Ze-Min Lin
Interplay of IL-17A/IL-17RA signaling with microbial homeostasis in systemic anti-tumoral responses. MedComm 5 (4) (2024)
Shijun He, Huihua Ding, Li Chen, Yiwei Shen, Yuting Liu, Fenghua Zhu, Xiaoqian Yang, Nan Shen, Ze-Min Lin, Jianping Zuo
Repression of interferon regulatory factor-4 (IRF4) hyperactivation restricts murine lupus. Signal transduction and targeted therapy 8 (1) (2023)
Shijun He, Huihua Ding, Li Chen, Yiwei Shen, Yuting Liu, Fenghua Zhu, Xiaoqian Yang, Nan Shen, Ze-Min Lin, Jianping Zuo
Repression of interferon regulatory factor-4 (IRF4) hyperactivation restricts murine lupus. Signal transduction and targeted therapy 8 (1) (2023)